title: [Primary hyperparathyroidism. Optimization of surgical results with systematic preoperative 99mTc-Sestamibi scintigraphy].
abstract: OBJECTIVE
  The importance of preoperative 99mTc Sestamibi (MIBI) scintigraphy in case of reoperation for persistent hyperparathyroidism is well recognized, but it use as a systematic exploration technique remains a question of debate. We conducted this study to determine whether preoperative MIBI scans performed in all cases before surgery have any real impact.
  
  
  METHODS
  Two successive series of 65 operated patients were included in the study. In the first group, the MIBI scan was not performed prior to surgery while in the second group the MIBI scan was part of the systematic work-up.
  
  
  RESULTS
  The sensitivity and positive predictive value of MIBI were 92% and 96% respectively. Sensitivity for unique adenomas was 95% and 80% for multiple forms. In the first group without systematic scans, there were two unproductive procedures. In the second group, all procedures were productive and no reoperations were required. Two mediastinal adenomas were removed at the first cervicotomy in this group. The rate of complications was similar for both groups. Mean operation time was 2 hours in the first group and 1 hour 30 minutes for the second.
  
  
  CONCLUSIONS
  Our series shows that there are three main advantages of using MIBI scintigraphy systematically prior to surgery for hyperparathyroidism: the procedure is easier in patients with cervical adenomas, particularly in case of ectopic localizations; the mean duration of the operation is shortened by 30 minutes; mediastinal ectopic localizations can be removed by sternotomy at the first operation. These advantages appear to be great enough to propose systematic use of MIBI scan prior to surgery. When MIBI scan shows a single gland, the risk of missing a multiple localization is less than 2% in our experience. It appears possible to operate under local anesthesia via a single-sided approach in elderly patients or high-risk patients.
authors.affiliation: Service de Chirurgie vasculaire et endocrinienne, CHU Henri Mondor, Créteil.
authors.forename: D
authors.initials: D
authors.lastname: Melliere
authors.forename: E
authors.initials: E
authors.lastname: Hindie
authors.forename: M C
authors.initials: MC
authors.lastname: Voisin
authors.forename: L
authors.initials: L
authors.lastname: Perlemuter
authors.forename: D
authors.initials: D
authors.lastname: Simon
mesh_terms: D000236:Adenoma / Q000000981:diagnostic imaging / Q000601:surgery; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi
chemical_list: D017256:Technetium Tc 99m Sestamibi
vernacular_title: Hyperparathyroïdie primaire. Optimisation des résultats chirurgicaux par la scintigraphie au 99mTc-Sestamibi pré-opératoire systématique.